Form 8-K - Current report:
SEC Accession No. 0000950170-25-037927
Filing Date
2025-03-12
Accepted
2025-03-12 16:08:49
Documents
12
Period of Report
2025-03-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K allk-20250312.htm   iXBRL 8-K 46217
2 EX-99.1 allk-ex99_1.htm EX-99.1 214621
  Complete submission text file 0000950170-25-037927.txt   384908

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT allk-20250312.xsd EX-101.SCH 25028
15 EXTRACTED XBRL INSTANCE DOCUMENT allk-20250312_htm.xml XML 4741
Mailing Address 825 INDUSTRIAL ROAD SUITE 500 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD SUITE 500 SAN CARLOS CA 94070 650-597-5002
Allakos Inc. (Filer) CIK: 0001564824 (see all company filings)

EIN.: 454798831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38582 | Film No.: 25731798
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)